Context The Primary Care Evaluation of Mental Disorders (PRIME-MD) was deve
loped as a screening instrument but its administration time has limited its
clinical usefulness.
Objective To determine if the self-administered PRIME-MD Patient Health Que
stionnaire (PHQ) has validity and utility for diagnosing mental disorders i
n primary care comparable to the original clinician-administered PRIME-MD.
Design Criterion standard study undertaken between May 1997 and November 19
98.
Setting Eight primary care clinics in the United States.
Participants Of a total of 3000 adult patients (selected by site-specific m
ethods to avoid sampling bias) assessed by 62 primary care physicians (21 g
eneral internal medicine, 41 family practice), 585 patients had an intervie
w with a mental health professional within 48 hours of completing the PHQ.
Main Outcome Measures Patient Health Questionnaire diagnoses compared with
independent diagnoses made by mental health professionals; functional statu
s measures; disability days; health care use; and treatment/referral decisi
ons.
Results A total of 825 (28%) of the 3000 individuals and 170 (29%) of the 5
85 had a PHQ diagnosis. There was good agreement between PHQ diagnoses and
those of independent mental health professionals (for the diagnosis of any
1 or more PHQ disorder, kappa = 0.65; overall accuracy, 85%; sensitivity, 7
5%; specificity, 90%), similar to the original PRIME-MD. Patients with PHQ
diagnoses had more functional impairment, disability days, and health care
use than did patients without PHQ diagnoses (for all group main effects, P<
.001), The average time required of the physician to review the PHQ was far
less than to administer the original PRIME-MD (<3 minutes for 85% vs 16% o
f the cases). Although 80% of the physicians reported that routine use of t
he PHQ would be useful, new management actions were initiated or planned fo
r only 117 (32%) of the 363 patients with 1 or more PHQ diagnoses not previ
ously recognized.
Conclusion Our study suggests that the PHQ has diagnostic validity comparab
le to the original clinician-administered PRIME-MD, and is more efficient t
o use.